Aquestive Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AQST research report →
Companywww.aquestive.com
Aquestive Therapeutics, Inc. , a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder.
- CEO
- Daniel Barber
- IPO
- 2018
- Employees
- 142
- HQ
- Warren, NJ, US
Price Chart
Valuation
- Market Cap
- $414.11M
- P/E
- -7.42
- P/S
- 8.24
- P/B
- -15.01
- EV/EBITDA
- -7.89
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 63.45%
- Op Margin
- -111.18%
- Net Margin
- -137.08%
- ROE
- 190.87%
- ROIC
- -44.82%
Growth & Income
- Revenue
- $44.55M · -22.61%
- Net Income
- $-83,784,000 · -89.83%
- EPS
- $-0.76 · -49.02%
- Op Income
- $-69,650,279
- FCF YoY
- -47.54%
Performance & Tape
- 52W High
- $7.55
- 52W Low
- $2.22
- 50D MA
- $4.15
- 200D MA
- $4.87
- Beta
- 1.50
- Avg Volume
- 1.76M
Get TickerSpark's AI analysis on AQST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 18, 26 | Zalewski Thomas A. | other | 100,000 |
| May 18, 26 | Zalewski Thomas A. | other | 75,000 |
| May 15, 26 | Barber Daniel | sell | 8,257 |
| May 15, 26 | Cioffi Melina | other | 1,667 |
| May 7, 26 | BRAENDER LORI J | other | 135,690 |
| May 5, 26 | Boyd Peter E. | other | 56,778 |
| May 5, 26 | Barber Daniel | other | 335,922 |
| May 5, 26 | TOTH A ERNEST JR | other | 92,652 |
| May 5, 26 | Jung Cassie | other | 72,734 |
| May 5, 26 | BRAENDER LORI J | other | 76,147 |
Our AQST Coverage
We haven't published any research on AQST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AQST Report →